Annual Report 2018

Department of Safety Management, Office of Infection Control and Prevention

Satoshi Iwata, Shunsuke Tsukamoto, Minoru Esaki, Mika Shiotsuka, Yukako Kuguminato, Mimiko Muroya, Tomomi Sano, Tomohisa Asano, Kouji Yamada, Ikue Ohmori

Introduction

 The mission of the Office of Infection Control and Prevention is to prevent and control healthcare-associated infections in cancer patients who undergo various cancer care including highly advanced cancer treatments. The office consists of infectious disease specialists, certified nurses in infection control, board certified pharmacists in infection control, an infection control microbiological technologist, and an office clerk. We execute our tasks in collaboration with the Infection Control Team and the Antimicrobial Stewardship Team which consists of crosssectional members from various areas throughout out hospital. We also collaborate with "link nurses" to facilitate appropriate infection control practice in each ward.

The Team and What We Do

• Advise the infection control and prevention, especially focusing on healthcare-associated infections, problematic pathogens including multidrug-resistant bacteria, and occupational infections.
• Consult with physicians on appropriate diagnosis of and treatment for infectious diseases. (Table)
• Implement antimicrobial stewardship strategy based on the local data from our hospital and the current clinical evidence. (Table)

Table 1. Number of supported patients in ICT/AST rounds

• Take weekly rounds in the wards to monitor environmental maintenance and compliance with the Infection Prevention and Control Manual.
• Conduct surveillance for healthcare-associated infections and drug-resistant bacteria.
• Provide education for the staff on standard practices regarding infection control and prevention with up-to-date evidence.
• Check for immunization status of the hospital staff and vaccinate those with insufficient protective immunity.
• Advise on building and refurbishment projects from the aspect of infection control.
• Hold conferences or mutual site visits with other regional hospitals to promote improvement in the infection control and prevention practices of one another.

Research activities

• Effective education of infection control practice, especially medical device management.
• Surveillance for surgical site infections.
• Appropriate dosing of antimicrobial drugs in cancer patients.
• Ideal system of infection control for cancer center in Japanese medical care system.
• Mechanism of antimicrobial resistance of multi drug resistant strain of Enterobacteriaceae isolated from cancer patient.
• Molecular epidemiology of Streptococci and Mycoplasma pneumoniae.
• Epidemiology of bacterial meningitis in Japan.

Education

 Training for infection control and management of infectious diseases in physicians and medical personnel.

Future prospects

 Our final goal is to establish an ideal and feasible model for infection control systems for cancer centers in Japan.